Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSL | P07711 | 20/20 | 0.86 |
| ▸ | CTSS | P25774 | 18/20 | 0.86 |
| ▸ | CTSK | P43235 | 17/20 | 0.86 |
| ▸ | CTSB | P07858 | 16/20 | 0.86 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4672212 | 1.00 | CTSL (0.86) | CTSLCTSSCTSKCTSB | |
| SCHEMBL2156992 | 0.93 | CTSL (1.00) | CTSLCTSSCTSKCTSB | |
| SCHEMBL2156187 | 0.93 | CTSL (1.00) | CTSLCTSSCTSKCTSB | |
| SCHEMBL24199878 | 0.87 | CTSL (0.78) | CTSLCTSSCTSKCTSB | |
| SCHEMBL2155860 | 0.87 | CTSL (0.78) | CTSLCTSSCTSKCTSB | |
| SCHEMBL2155531 | 0.86 | CTSL (0.87) | CTSLCTSSCTSKCTSB | |
| SCHEMBL2155862 | 0.85 | CTSL (0.87) | CTSLCTSSCTSKCTSB | |
| SCHEMBL4672510 | 0.85 | CTSL (0.87) | CTSLCTSSCTSKCTSB | |
| SCHEMBL4675914 | 0.85 | CTSL (0.87) | CTSLCTSSCTSKCTSB | |
| SCHEMBL2156423 | 0.84 | CTSL (0.84) | CTSLCTSSCTSKCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110230446-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2011-09-22 | — | — | US | claimed |
| US-7973037-B2 | Cathepsin cysteine protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2011-07-05 | — | — | US | claimed |
| US-20110230446-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2011-09-22 | — | — | US | disclosed |
| US-7973037-B2 | Cathepsin cysteine protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2011-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230446-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | CTSB, CTSS, CTSZ | CTSL 8/4885CTSS 2/4885CTSK 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.